Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126857732 | 12685773 | 2 | F | 20160709 | 20160831 | 20160825 | 20160906 | EXP | FR-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-067516 | BRISTOL MYERS SQUIBB | 73.60 | YR | F | Y | 70.00000 | KG | 20160906 | CN | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126857732 | 12685773 | 1 | PS | COUMADINE | WARFARIN SODIUM | 1 | Oral | UNK | U | 9218 | TABLET | ||||||||
| 126857732 | 12685773 | 2 | SS | ASPEGIC | ASPIRIN DL-LYSINE | 1 | Oral | 100 MG, QD | U | 0 | 100 | MG | QD | ||||||
| 126857732 | 12685773 | 3 | C | NOCTAMIDE | LORMETAZEPAM | 1 | Unknown | 1 MG, UNK | U | 0 | 1 | MG | |||||||
| 126857732 | 12685773 | 4 | C | LYRICA | PREGABALIN | 1 | Unknown | 1 DF, BID | U | 0 | 1 | DF | BID | ||||||
| 126857732 | 12685773 | 5 | C | LOXEN /00639802/ | NICARDIPINE | 1 | Unknown | 1 DF, QD | U | 0 | 1 | DF | QD | ||||||
| 126857732 | 12685773 | 6 | C | VASTEN /00880402/ | PRAVASTATIN SODIUM | 1 | Unknown | 1 DF, QD | U | 0 | 1 | DF | QD | ||||||
| 126857732 | 12685773 | 7 | C | MOPRAL /00661201/ | OMEPRAZOLE SODIUM | 1 | Unknown | U | 0 | ||||||||||
| 126857732 | 12685773 | 8 | C | DOLIPRANE | ACETAMINOPHEN | 1 | Unknown | U | 0 | ||||||||||
| 126857732 | 12685773 | 9 | C | MOVICOL | POLYETHYLENE GLYCOL 3350POTASSIUM CHLORIDESODIUM BICARBONATESODIUM CHLORIDE | 1 | Unknown | U | 0 | ||||||||||
| 126857732 | 12685773 | 10 | C | LASILIX /00032601/ | FUROSEMIDE | 1 | Unknown | 1 DF, QD | U | 0 | 1 | DF | QD | ||||||
| 126857732 | 12685773 | 11 | C | ARIMIDEX | ANASTROZOLE | 1 | Unknown | 1 DF, QD | U | 0 | 1 | DF | QD | ||||||
| 126857732 | 12685773 | 12 | C | SERESTA | OXAZEPAM | 1 | Unknown | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126857732 | 12685773 | 1 | Product used for unknown indication |
| 126857732 | 12685773 | 2 | Product used for unknown indication |
| 126857732 | 12685773 | 3 | Product used for unknown indication |
| 126857732 | 12685773 | 4 | Product used for unknown indication |
| 126857732 | 12685773 | 5 | Product used for unknown indication |
| 126857732 | 12685773 | 6 | Product used for unknown indication |
| 126857732 | 12685773 | 7 | Product used for unknown indication |
| 126857732 | 12685773 | 8 | Product used for unknown indication |
| 126857732 | 12685773 | 9 | Product used for unknown indication |
| 126857732 | 12685773 | 10 | Product used for unknown indication |
| 126857732 | 12685773 | 11 | Product used for unknown indication |
| 126857732 | 12685773 | 12 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126857732 | 12685773 | LT |
| 126857732 | 12685773 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126857732 | 12685773 | Anaemia | |
| 126857732 | 12685773 | Epistaxis | |
| 126857732 | 12685773 | Respiratory distress | |
| 126857732 | 12685773 | Transfusion |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126857732 | 12685773 | 1 | 20160712 | 0 |